Harvard Apparatus Regenerative Technology, Inc. (HRGN): Submission of Matters to a Vote of Security Holders

Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. hrgn20260623_8k.htm false 0001563665 0001563665 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event repo

Event · Shareholder vote
Original reporting
Published Jun 23, 2026, 11:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 24, 2026, 10:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$HRGN
Neutral
high confidence
Mentioned
$HRGN
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HRGNNeutralLow
01

Why it matters

The disclosure confirms directors were elected, CBIZ CPAs P.C. was ratified as independent auditor for FY ending Dec. 31, 2026, and named executive compensation received advisory approval; it does not introduce new operating or financial commitments.

02

Market read

Primarily governance/administrative confirmation; unlikely to drive trading without additional concurrent catalysts.

03

What to watch

Vote tallies alone rarely change valuation; traders should look for separate disclosures (financing, clinical/regulatory, contracts) for actionable catalysts.

Relevance 6/10Novelty 2/10Timing: after-hours/filing update following the June 18, 2026 annual meeting

Background

The company’s SEC 8-K (Item 5.07) summarizes stockholder votes from its June 18, 2026 annual meeting.

Company-level read

Ticker impact

$HRGNNeutralHigh confidence
Context

HRGN filed an 8-K reporting June 18, 2026 annual meeting results: director elections, auditor ratification, and advisory executive comp approval.

Expected impact

Limited near-term impact; any reaction likely muted unless investors were focused on governance/auditor continuity.

Evidence & confidence

The filing is a standard Item 5.07 disclosure with vote tallies and no accompanying material corporate action beyond non-binding advisory compensation approval.

Market effects

No sector read-through; this is company-specific governance voting disclosure.

None indicated.

None indicated.

Counterpoint

If investors were concerned about auditor continuity or board composition, the approval could reduce uncertainty, but the filing still lacks new fundamentals.

Key entities

  • Harvard Apparatus Regenerative Technology, Inc.

    Subject of the 8-K; reported annual meeting voting results (director election, auditor ratification, advisory comp approval).

  • CBIZ CPAs P.C.

    Independent registered public accounting firm ratified for the fiscal year ending December 31, 2026.

Related articles

$DJTMed

How Low Can Bitcoin Fall Before Trump Media Has to Sell?

Trump Media & Technology Group (DJT) may sell Bitcoin (BTC) to repay debt by November 30. With 9,542 BTC valued at $580M, a price drop increases the number of coins needed to meet obligations. Noteholders can demand $883.5M in cash, and DJT's stock is trading far below the conversion price of its notes.

$NEEMed

NextEra Energy Is Slowing Dividend Growth From 10% to 6%. Here’s Why

NextEra Energy (NEE) plans to reduce its dividend growth rate from 10% to 6% annually from 2026 through 2028. The company's earnings per share (EPS) are expected to grow at an 8%+ annual rate through 2035, providing a buffer for dividend increases. NextEra faces cash flow pressures due to heavy capital spending, but management expects operating cash flow to keep pace with EPS growth. The company's shares closed at $83.45 on November 20, with a forward dividend yield of 2.87%.

$MNTKMed

Tycoon Johnny Copelyn's Montauk warns of year-end default

Montauk Renewables Inc., chaired by Johnny Copelyn, warned of a potential default on loan covenants by Dec. 31, 2026, unless lenders agree to relief. The company's cash reserves halved this year, while long-term debt and accounts payable increased. Revenue rose 10.9% to $50.2 million, but net income fell 59% to $2.1 million. The company cut its 2026 revenue forecast due to lower prices for environmental attributes and operational issues at its Turkey, North Carolina facility.